Search icon

CAPITAL RX, INC.

Company claim

Is this your business?

Get access!

Company Details

Name: CAPITAL RX, INC.
Jurisdiction: New York
Legal type: FOREIGN BUSINESS CORPORATION
Status: Active
Date of registration: 16 Jul 2019 (6 years ago)
Entity Number: 5587679
ZIP code: 10005
County: New York
Place of Formation: Delaware
Address: 28 LIBERTY STREET, NEW YORK, NY, United States, 10005
Principal Address: 228 PARK AVENUE S, SUITE 87234, NEW YORK, NY, United States, 10003

Agent

Name Role Address
C T CORPORATION SYSTEM Agent 28 LIBERTY STREET, NEW YORK, NY, 10005

DOS Process Agent

Name Role Address
C/O C T CORPORATION SYSTEM DOS Process Agent 28 LIBERTY STREET, NEW YORK, NY, United States, 10005

Chief Executive Officer

Name Role Address
ANTHONY JOSEPH LOIACONO Chief Executive Officer 228 PARK AVENUE S, SUITE 87234, NEW YORK, NY, United States, 10003

Form 5500 Series

Employer Identification Number (EIN):
352612946
Plan Year:
2020
Number Of Participants:
45
Sponsors Telephone Number:
Plan Year:
2019
Number Of Participants:
0
Sponsors Telephone Number:

History

Start date End date Type Value
2023-07-03 2023-07-03 Address 228 PARK AVENUE S, SUITE 87234, NEW YORK, NY, 10003, USA (Type of address: Chief Executive Officer)
2019-07-16 2023-07-03 Address 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Registered Agent)
2019-07-16 2023-07-03 Address 28 LIBERTY STREET, NEW YORK, NY, 10005, USA (Type of address: Service of Process)

Filings

Filing Number Date Filed Type Effective Date
230703002968 2023-07-03 BIENNIAL STATEMENT 2023-07-01
210707000575 2021-07-07 BIENNIAL STATEMENT 2021-07-07
190716000253 2019-07-16 APPLICATION OF AUTHORITY 2019-07-16

Trademarks Section

Serial Number:
97344844
Mark:
TRANSPARENT PMPM
Status:
ABANDONED - NO STATEMENT OF USE FILED
Mark Type:
SERVICE MARK
Application Filing Date:
2022-04-04
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
TRANSPARENT PMPM

Goods And Services

For:
Pharmaceutical benefits management services; reimbursement payment processing in the field of medical and pharmaceutical claims; insurance claims processing in the field of medical and pharmaceutical claims
International Classes:
036 - Primary Class
Class Status:
Active
For:
Providing a pricing program in the field of prescription benefit plans for enabling participants to obtain discounts on prescriptions
International Classes:
035 - Primary Class
Class Status:
Active
Serial Number:
90528834
Mark:
JUDI
Status:
REGISTERED
Mark Type:
SERVICE MARK
Application Filing Date:
2021-02-15
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
JUDI

Goods And Services

For:
Pharmaceutical benefits management services; reimbursement payment processing in the field of pharmaceutical claims; insurance claims processing in the field of pharmaceutical claims
First Use:
2019-11-19
International Classes:
036 - Primary Class
Class Status:
Active
For:
Software as a service (SAAS) services featuring software for processing pharmacy claims; platform as a service (PAAS) featuring computer software platforms for use in processing pharmacy claims
First Use:
2019-11-19
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
88909520
Mark:
CAPITAL RX
Status:
REGISTERED
Mark Type:
SERVICE MARK
Application Filing Date:
2020-05-11
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
CAPITAL RX

Goods And Services

For:
Pharmaceutical benefits management services; reimbursement payment processing in the field of medical and pharmaceutical claims; insurance claims processing in the field of medical and pharmaceutical claims
First Use:
2018-03-01
International Classes:
036 - Primary Class
Class Status:
Active
For:
Administration and management of pricing programs for pharmaceuticals; providing a pricing program in the field of prescription benefit plans
First Use:
2018-03-01
International Classes:
035 - Primary Class
Class Status:
Active
Serial Number:
88722652
Mark:
CLEARINGHOUSE MODEL
Status:
REGISTERED
Mark Type:
SERVICE MARK
Application Filing Date:
2019-12-11
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
CLEARINGHOUSE MODEL

Goods And Services

For:
Pharmaceutical benefits management services; reimbursement payment processing the the field of medical and pharmaceutical claims; insurance claims processing in the field of medical and pharmaceutical claims
First Use:
2020-01-01
International Classes:
036 - Primary Class
Class Status:
Active
For:
Administration and management of pricing programs for pharmaceuticals; providing a pricing program in the field of prescription benefit plans
First Use:
2020-01-01
International Classes:
035 - Primary Class
Class Status:
Active
For:
Platform-as-a-service (PAAS) featuring computer software platforms for use in prescription benefit plan management for health plans and other large payers
First Use:
2020-01-01
International Classes:
042 - Primary Class
Class Status:
Active
Serial Number:
98657697
Mark:
NEVER MOVE AGAIN
Status:
FINAL REFUSAL - MAILED
Mark Type:
SERVICE MARK
Application Filing Date:
2024-07-19
Mark Drawing Type:
Standard character mark
Mark Literal Elements:
NEVER MOVE AGAIN

Goods And Services

For:
Software as a service (SAAS) services featuring software for processing pharmacy claims; platform as a service (PAAS) featuring computer software platforms for use in processing pharmacy claims
International Classes:
042 - Primary Class
Class Status:
Active

Paycheck Protection Program

Date Approved:
2020-04-11
Loan Status:
Paid in Full
SBA Guaranty Percentage:
100
Initial Approval Amount:
931046
Current Approval Amount:
931046
Race:
Unanswered
Ethnicity:
Unknown/NotStated
Gender:
Unanswered
Veteran:
Unanswered
Forgiveness Amount:
940499.74

Court Cases

Court Case Summary

Filing Date:
2024-06-24
Status:
Pending
Nature Of Judgment:
Missing
Jury Demand:
Plaintiff demands jury
Nature Of Suit:
Defend Trade Secrets Act

Parties

Party Name:
CAPITAL RX, INC.
Party Role:
Plaintiff
Party Name:
KHAN,
Party Role:
Defendant

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 23 Mar 2025

Sources: New York Secretary of State